Markets:

Overview

News

Currencies

International

Treasuries

UroGen Pharma Ltd. - Ordinary Shares (NQ:URGN)

30.22 +1.96 (+6.94%)

Streaming Delayed Price Updated: 4:00 PM EDT, May 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about UroGen Pharma Ltd. - Ordinary Shares

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

The Daily Biotech Pulse: Pfizer Acquires Migraine Drugmaker For $11B, Biogen Files For Second Alzheimer's Drug Approval, Longeveron CEO Leaves ↗

May 10, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

UroGen Pharma Reports First Quarter 2022 Financial Results and Recent Corporate Developments

May 10, 2022

From UroGen Pharma Ltd.

Via Business Wire

Earnings Outlook For UroGen Pharma ↗

May 09, 2022

UroGen Pharma (NASDAQ:URGN) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that UroGen Pharma...

Via Benzinga

Recap: UroGen Pharma Q4 Earnings ↗

March 21, 2022

UroGen Pharma (NASDAQ:URGN) reported its Q4 earnings results on Monday, March 21, 2022 at 08:00 AM. Here's what investors need to know about the announcement. Earnings...

Via Benzinga

UroGen Pharma Earnings Preview ↗

March 18, 2022

UroGen Pharma (NASDAQ:URGN) is set to give its latest quarterly earnings report on Monday, 2022-03-21. Here's what investors need to know before the announcement. Analysts...

Via Benzinga

Earnings Scheduled For March 10, 2022 ↗

March 10, 2022

Companies Reporting Before The Bell • Despegar.com (NYSE:DESP) is expected to report quarterly loss at $0.08 per share on revenue of $110.93 million. • ProShares...

Via Benzinga

Earnings Scheduled For May 10, 2022 ↗

May 10, 2022

Companies Reporting Before The Bell • The Middleby (NASDAQ:MIDD) is expected to report quarterly earnings at $2.10 per share on revenue of $935.99 million.

Via Benzinga

UroGen Pharma to Report First Quarter 2022 Financial Results on Tuesday, May 10, 2022

May 03, 2022

From UroGen Pharma Ltd.

Via Business Wire

UroGen Announces FDA Clearance of IND Application for the Investigational Immunotherapy UGN-301 (zalifrelimab) Intravesical Solution in Recurrent Non-Muscle Invasive Bladder Cancer

March 29, 2022

From UroGen Pharma Ltd.

Via Business Wire

UroGen Pharma's Return On Capital Employed Overview ↗

March 22, 2022

According to data from Benzinga Pro, during Q4, UroGen Pharma's (NASDAQ:URGN) reported sales totaled $16.17 million. Despite a 5.82% increase in earnings, the company posted a...

Via Benzinga

UroGen Pharma Reports Fourth Quarter and Full-year 2021 Financial Results and Recent Corporate Developments

March 21, 2022

From UroGen Pharma Ltd.

Via Business Wire

Earnings Scheduled For March 21, 2022 ↗

March 21, 2022

Companies Reporting Before The Bell • Marinus Pharmaceuticals (NASDAQ:MRNS) is likely to report quarterly loss at $0.76 per share on revenue of $3.37 million. •...

Via Benzinga

How To Attend UroGen Pharma Q4 2021 Earnings Conference Call ↗

March 18, 2022

UroGen Pharma (NASDAQ:URGN) will host a conference call at 10:00 AM ET on March 21, 2022, to discuss Q4 2021 earnings results. How to Attend UroGen Pharma (URGN) Conference Call...

Via Benzinga

Earnings Outlook For UroGen Pharma ↗

March 18, 2022

UroGen Pharma (NASDAQ:URGN) is set to give its latest quarterly earnings report on Monday, 2022-03-21. Here's what investors need to know before the announcement. Analysts...

Via Benzinga

UroGen Pharma Q4 2021 Earnings Conference Call On March 21, 2022 At 10:00 AM ET ↗

March 17, 2022

UroGen Pharma (NASDAQ:URGN) will host a conference call at 10:00 AM ET on March 21, 2022, to discuss Q4 2021 earnings results. How to Attend UroGen Pharma (URGN) Conference Call...

Via Benzinga

Earnings Outlook For UroGen Pharma ↗

March 09, 2022

UroGen Pharma (NASDAQ:URGN) is set to give its latest quarterly earnings report on Thursday, 2022-03-10. Here's what investors need to know before the announcement. Analysts...

Via Benzinga

88 Biggest Movers From Yesterday ↗

March 09, 2022

Gainers Hycroft Mining Holding Corporation (NASDAQ: HYMC) climbed 203.3% to settle at $1.00 on Tuesday. Hycroft recently reported preliminary FY21 operating results. Kala...

Via Benzinga

UroGen Pharma to Participate in Panel Discussion at Cowen 42nd Annual Healthcare Conference

February 28, 2022

From UroGen Pharma Ltd.

Via Business Wire

Stocks That Hit 52-Week Lows On Tuesday ↗

February 22, 2022

During Tuesday's trading, 505 companies set new 52-week lows. Noteworthy Highlights From Today's 52-Week Lows: The company with the largest market cap to...

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

February 18, 2022

On Friday, 313 companies hit new 52-week lows. Things to Consider About Today's 52-Week Lows: The largest company in terms of market cap to set a new 52-week...

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

February 17, 2022

On Thursday, 147 companies achieved new lows for the year. Significant Points From Today's 52-Week Lows: PayPal Holdings (NASDAQ:PYPL) was the biggest company...

Via Benzinga

UroGen Announces Data that Shows In-Office Nephrostomy Tube Administration of Jelmyto® is Efficient for Doctors and Well Tolerated by Patients

February 10, 2022

From UroGen Pharma Ltd.

Via Business Wire

UroGen Announces Start of Pivotal Single-Arm Phase 3 Trial for UGN-102, an Investigational Non-Surgical Treatment for Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer

February 03, 2022

From UroGen Pharma Ltd.

Via Business Wire

UroGen Pharma to Present at Upcoming Conferences

January 05, 2022

From UroGen Pharma Ltd.

Via Business Wire

First Patient Dosed in UroGen Pharma’s Home Instillation Study of UGN-102 in Patients with Low-Grade Intermediate Risk Non-Muscle Invasive Bladder Cancer (LG IR-NMIBC)

December 21, 2021

From UroGen Pharma Ltd.

Via Business Wire

Stocks That Hit 52-Week Lows On Friday ↗

January 14, 2022

During Friday's session, 445 companies made new 52-week lows. Noteable 52-Week Lows: Intuitive Surgical (NASDAQ:ISRG) is the largest company in terms of market cap to...

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

January 06, 2022

On Thursday, 615 stocks hit new 52-week lows. Noteable 52-Week Lows: Sea (NYSE:SE) is the largest company in terms of market cap to set a new 52-week low this...

Via Benzinga

UroGen Pharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

December 03, 2021

From UroGen Pharma Ltd.

Via Business Wire

70 Biggest Movers From Yesterday ↗

November 16, 2021

Gainers Casper Sleep Inc. (NYSE: CSPR) shares jumped 88.5% to close at $6.69 on Monday after the company agreed to be acquired by Durational Capital Management. The...

Via Benzinga

UroGen Pharma Reports Third Quarter 2021 Financial Results and Recent Corporate Developments

November 15, 2021

From UroGen Pharma Ltd.

Via Business Wire

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

UroGen Pharma Ltd. - Ordinary Shares (NQ:URGN)

All News about UroGen Pharma Ltd. - Ordinary Shares

Starting at $3.75/week.

Subscribe Today